Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Sudarshan Pharma Industries's share price is ₹36.31.
Sudarshan Pharma Industries's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹28.95. Hence, Sudarshan Pharma Industries's PS Ratio for today is 1.25.
The historical rank and industry rank for Sudarshan Pharma Industries's PS Ratio or its related term are showing as below:
BOM:543828'
s PS Ratio Range Over the Past 10 Years
Min: 0.77 Med: 1.36 Max: 10.19
Current: 1.25
During the past 10 years, Sudarshan Pharma Industries's highest PS Ratio was 10.19. The lowest was 0.77. And the median was 1.36.
BOM:543828's PS Ratio is ranked better than 56.35% of 1576
companies
in the Chemicals industry
Industry Median: 1.45
vs BOM:543828: 1.25
During the past 10 years, Sudarshan Pharma Industries's highest 3-Year average Revenue per Share Growth Rate was 188.30% per year. The lowest was -6.60% per year. And the median was 12.10% per year.
Sudarshan Pharma Industries (BOM:543828) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Sudarshan Pharma Industries PS Ratio Related Terms
Sudarshan Pharma Industries PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Sudarshan Pharma Industries's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sudarshan Pharma Industries PS Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Sudarshan Pharma Industries's PS Ratio distribution charts can be found below:
* The bar in red indicates where Sudarshan Pharma Industries's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Sudarshan Pharma Industries's Share Price of today is ₹36.31. Sudarshan Pharma Industries's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹28.95.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Sudarshan Pharma Industries (BOM:543828) has a PS Ratio of 1.25 as of Aug. 15, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Sudarshan Pharma Industries and its competitors. This is near median its historical median of 1.36. Over the past decade, Sudarshan Pharma Industries' PS Ratio has ranged from 0.77 to 10.19. According to the industry distribution chart, Sudarshan Pharma Industries ranks #688 out of 1576 companies in the Chemicals industry, placing it in the top 43.7%.
Is Sudarshan Pharma Industries' PS Ratio too high?
Sudarshan Pharma Industries' current PS Ratio of 1.25 is near median its 10-year median of 1.36. Over the past 10 years, this metric has ranged from a low of 0.77 to a high of 10.19. The Chemicals industry median PS Ratio is 1.45. Sudarshan Pharma Industries' value of 1.25 is 13.8% below this industry median. Based on the distribution chart, Sudarshan Pharma Industries ranks #688 out of 1576 companies in the Chemicals industry, which is above the industry midpoint. Overall, Sudarshan Pharma Industries has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sudarshan Pharma Industries' PS Ratio compare to DOW?
According to the Chemicals industry distribution chart, Sudarshan Pharma Industries ranks #688 out of 1576 companies for PS Ratio. This puts Sudarshan Pharma Industries in the upper half of its industry. The industry median PS Ratio is 1.45. Sudarshan Pharma Industries' value of 1.25 is 13.8% below this benchmark. Historically, Sudarshan Pharma Industries' own PS Ratio has ranged from 0.77 to 10.19 over the past decade. While the company's 10-year median is 1.36 vs. the industry median of 1.45, Sudarshan Pharma Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Chemicals company?
The median PS Ratio among Chemicals companies is 1.45, based on 1,576 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sudarshan Pharma Industries's current PS Ratio of 1.25 is 13.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Sudarshan Pharma Industries and its competitors. For the Chemicals industry, the median PS Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sudarshan Pharma Industries's current PS Ratio is 1.25, which is near median its own 10-year median of 1.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sudarshan Pharma Industries stock overvalued right now?
Based on GuruFocus' analysis, Sudarshan Pharma Industries (BOM:543828) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹6.51, compared to a current price of ₹36.31 — trading 457.8% above its estimated fair value. The current PS Ratio is 1.25, which is near median its 10-year median of 1.36 and 13.8% below the Chemicals industry median of 1.45. Sudarshan Pharma Industries' overall GF Score™ is 69/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Sudarshan Pharma Industries (BOM:543828), the current PS Ratio is 1.25 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sudarshan Pharma Industries (BOM:543828) Overvalued in 2026?
Based on GuruFocus' analysis, Sudarshan Pharma Industries stock appears to be overvalued.
The current stock price of ₹36.31 is trading 457.8% above its estimated GF Value™ of ₹6.51.
GuruFocus considers Sudarshan Pharma Industries to be Significantly Overvalued.
Key valuation signals for BOM:543828:
PS Ratio: 1.25 (near median its 10-year median of 1.36)
GF Value™: ₹6.51 vs. price of ₹36.31 (457.8% above fair value)
Industry Position: 13.8% below the Chemicals median (#688 of 1576)
No single metric tells the full story. See the BOM:543828 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sudarshan Pharma Industries Ltd operates in the pharmaceutical and chemical industries, focusing on specialty chemicals and intermediates used in pharmaceuticals, paints, food products, and adhesives. The Company has a presence domestically and internationally, participating regularly in trade fairs and exhibitions. The Company exports mainly to South East Asia, the Middle East, and North Africa. The Company also supplies generic pharmaceutical formulation as 'Make to order' for bulk supply to hospitals and related healthcare organisations. The company has one reportable segment of Specialty Chemicals.
69GF Score
Get the complete analysis for BOM:543828
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543828 has been successfully added to your 
